Mazdutide 5 mg research peptide

Buy Mazdutide 5 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

It is a modified peptide studied at glucagon-like peptide-1 (GLP-1) and glucagon receptors.

Choose the presentation and named analog

The Mazdutide 10 mg presentation provides a different amount of the same named compound. The milligram value is the labeled quantity in the vial, not a liquid concentration or a measure of receptor potency.

Survodutide 10 mg is another compound studied at GLP-1 and glucagon receptors. It is a distinct analog, not an alternative name for Mazdutide. Shared receptor targets do not establish equal activity or make the materials interchangeable.

“Dual agonist” describes activity at two receptor types. Mazdutide is one modified peptide, rather than a mixture containing separate GLP-1 and glucagon ingredients.

Connecting the name to the research literature

The original Ji and colleagues publication identifies Mazdutide by the development names IBI362 and LY3305677. Those identifiers help locate studies on the same named analog and distinguish it from other dual-receptor compounds.

That publication reports a clinical trial of a defined investigational formulation. It is cited here for nomenclature and receptor context, not as evidence of this powder’s formulation, clinical suitability or expected effects.

For laboratory comparisons, match the specified peptide form and modifications to the material record. A shared name or receptor category cannot replace that identity check.

Available product records

Use Documents to review the available files. Check identity, labeled amount and any analytical measurements separately. Any certificate used in the evaluation should correspond to the supplied product and lot; a chromatographic purity result alone does not quantify the whole vial.

Follow storage and handling information that applies to the supplied formulation. The 3 mL vial capacity does not specify a liquid fill volume or a preparation procedure.